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INTRODUCTION
normalisation effects of fluoxetine on abnormal brain activation in ADHD patients under placebo, we also compared brain activation during both drug conditions to that of healthy adolescents.
Based on previous findings, we hypothesized that ADHD adolescents under placebo would show steeper TD rates (Noreika et al., 2013) and reduced IFC-insular-striatal activation during TD (Chantiluke et al., 2014d , Plichta et al., 2009 , Rubia et al., 2009 . Furthermore, based on our fMRI studies showing upregulation and normalisation with fluoxetine in task-relevant regions during related tasks of cognitive control in ADHD (Chantiluke et al., 2014a , Chantiluke et al., 2014b , Chantiluke et al., 2014c , and evidence for 5-HT modulation of IFC-striatal regions in healthy adults (Lamar et al., 2009 , Rubia et al., 2005 , we hypothesized that fluoxetine would upregulate IFC-insulastriato-parietal activation within patients and normalise regional underactivation relative to controls.
METHODS

Participants
Thirty-two right-handed (Oldfield, 1971) boys with (N=12) and without ADHD (N=20) were recruited from local clinics and support groups, aged 11-17 years, with IQ>70 measured by the Wechsler Abbreviated Scale of Intelligence-Revised (WASI-R) short form (Wechsler, 1999) . ADHD boys had a clinical DSM-IV diagnosis of non-comorbid ADHD, inattentive/hyperactive-impulsive combined subtype, assessed using the standardized Maudsley diagnostic interview (Goldberg and Murray, 2006) . Patients scored above clinical threshold for ADHD symptoms on the Strengths and Difficulties Questionnaire (SDQ; (Goodman and Scott, 1999) ) and the Conner's Parent Rating ScaleRevised (CPRS-R; (Conners et al., 1998) ). They also scored below clinical threshold for ASD on the Social Communication Questionnaire (SCQ; (Rutter et al., 2003) ). Nine ADHD boys were on psychostimulants but withheld medication for 48 hours prior to scanning.
Patients were scanned twice in a randomised, double-blind, placebo-controlled design. Due to the half-life of fluoxetine (1-3 days) and its metabolite norfluoxetine (5-16 days) (Wong et al., 1995) , scans were conducted 3-4 weeks apart. To ensure the fluoxetine dose had reached peak plasma levels (after 5-8 hours (Wong et al., 1995) ), patients were scanned 5 hours postadministration. Liquid fluoxetine was titrated to age and weight: boys 10-13 years and <30kg received 8mg, those >30kg received 10mg. Boys 14-17 years and <30kg received 10mg, and those >30kg received 15mg. Placebo was equivalent volumes of peppermint water, similar in taste and appearance to fluoxetine.
Twenty healthy age and handedness-matched control boys were recruited locally by advertisement and scanned once. Controls scored below clinical threshold on the SDQ, SCQ and CPRS-R and did not have any psychiatric condition.
Exclusion criteria for all participants were neurological disorders, drug/alcohol dependency and MRI contraindications.
The study was conducted according to the latest version of the Declaration of Helsinki.
Ethical approval was obtained from the local Research Ethics Committee. Study details were explained to both child and guardian, and written informed consent was obtained for all participants.
Temporal Discounting fMRI paradigm
Prior to the first scan, subjects practiced the 12 min task once in a 'mock' scanner. Subjects choose by pressing a left or right button between receiving a small amount of money immediately (£0-£100) or £100 in one week, month or year. Delay choices (20 trials of each delay length) were randomised, but the delayed option was consistently displayed on the right side, and the variable immediate choices on the left side of the screen to minimize potential sensorimotor mapping effects. Choices were displayed for 4s, followed by a blank screen of at least 8s (inter-trial-interval: 12s). The amount of immediate reward was adjusted through an algorithm based on previous choices which was calculated separately for each of the three delays. This narrows the range of values, converging into an indifference point where the immediate reward is considered by the subject to be equivalent to the delayed amount for the given delay (Christakou et al., 2011 , Rubia et al., 2009 . This algorithm ensures equal numbers of immediate and delayed choices to be contrasted in the fMRI analysis.
Analysis of Performance Data
To estimate the steepness of TD for each subject, the indifference value between the immediate amount and the delayed £100 for each delay was calculated, equivalent to the subject's subjective value of £100 after each delay, and defined as the midpoint between the lowest immediate reward chosen by the subject and the next lowest immediate reward available (i.e. the value of the immediate reward offered at which point the subject began to instead consistently choose the delayed reward) (Christakou et al., 2011 , Rubia et al., 2009 .
Reward is typically discounted as a hyperbolic decay function depending on amount, delay and a free impulsiveness indicator "k", calculated by fitting a hyperbolic function to the indifference values for each delay (see Supplement).
However, the limitations of the fMRI task adaption, i.e. relatively few trials and only three delay points, limit the goodness-of-fit of the data to a non-linear curve function. In addition, the distribution of k-values was not normal, skewed by low-frequency and high-value outliers. Thus, TD was measured using the area under the curve (AUC) which is more appropriate for investigations with quantitative, inferential statistics (Myerson et al., 2001) . The normalized subjective values of the delayed £100 for each delay were plotted against the normalized delays and AUC of these plots were calculated for each participant, using this obtained value as the main dependent variable. AUC correlated inversely with k-values (r=-0.898, p<0.001) whereby smaller AUC values denote steeper discounting rates, indicating increased choice impulsivity.
A repeated-measures within-group analysis of variance (ANOVA) was conducted within patients with medication condition (placebo, fluoxetine) as within-subjects variable to test for medication effects on TD. Two ANOVAs were conducted with group as independent variable and area under the curve (AUC) as dependent measure to test for differences in TD performance between controls and ADHD patients on either placebo or fluoxetine. To test for potential main effects of drug administration order and of an interaction between order and drug condition, order was included as a between-subjects factor in the repeated-measures ANOVA.
fMRI Image Acquisition
Gradient-echo echo-planar MR imaging (EPI) data were acquired at King's College London, Institute of Psychiatry's Centre for Neuroimaging Sciences on a 3T General Electric SIGNA HDx MRI scanner (GE Healthcare, UK). For details of scan acquisition, see Supplement.
fMRI Image Analysis
Event-related activation data were acquired in randomized trial presentation and analysed using the non-parametric XBAM software package developed at the Institute of Psychiatry, King's College London (www.brainmap.co.uk; (Brammer et al., 1997) ). The individual and group-level analyses methods are described in detail elsewhere (Brammer et al., 1997 , Bullmore et al., 1999a , Bullmore et al., 2001 , Bullmore et al., 1999b , Cubillo et al., 2014b and in the online Supplementary Material.
ANCOVA of within-patient medication effects
To investigate medication effects on brain activation within the ADHD group, a within-group repeated-measures analysis of covariance (ANCOVA) with motion as covariate and medication condition as within-subjects factor was conducted using randomization-based testing for voxel or cluster-wise differences, as described elsewhere (Bullmore et al., 2001 , Bullmore et al., 1999b and in the supplementary material. Voxel-and cluster-level statistical thresholds were set so as to obtain less than one false positive 3D cluster per map ( p<0.05 was used for voxel and p<0.005 for cluster comparisons). The standardised BOLD response values for each participant were extracted for each of the significant clusters of the ANCOVA analyses and plotted to determine the direction of effects. Repeated-measures ANOVAs on the extracted BOLD response measures were conducted within patients to test for potential effects of scan-order and interactions between scan order and drug condition.
ANCOVA of between-group effects
One-way ANCOVAs with group as main factor and motion as covariate were conducted using randomization-based testing to test for case-control differences under placebo or fluoxetine (Bullmore et al., 2001 , Bullmore et al., 1999b . For these comparisons, p<0.05 (voxel-level) and p<0.05 (cluster-level) were used. Standardized BOLD responses were then extracted from significant clusters for each participant and plotted to determine direction of effects.
Correlations with behaviour and IQ
To examine whether clusters which showed group effects in case-control comparisons were related to IQ or TD, the BOLD response in these clusters was extracted for each participant and Pearson correlations were performed with IQ and AUC within each group (ADHD placebo, ADHD fluoxetine, controls).
RESULTS
Participant characteristics
Univariate ANOVA revealed no significant group differences in age, but IQ, which was lower in ADHD (Table 1) . However, since low IQ is associated with ADHD (Bridgett and Walker, 2006), IQ was not covaried as covarying for differences between groups that were not randomly selected violates ANCOVA assumptions (Miller and Chapman, 2001) . Nonetheless, to assess potential effects of IQ on case-control comparisons, BOLD responses were correlated with IQ and analyses were repeated covarying for IQ. As expected, patients had significantly lower CPRS-R t-scores, SDQ and SCQ scores than controls (Table 1) [F(df=2,29)=2.54, p=n.s] . Nevertheless, to exclude potential effects of non-significant motion, motion parameters in 3D-Euclidian space were included as covariates in the fMRI analyses.
Group brain activation maps for delayed-immediate choices
For the contrast of delayed minus immediate choices, controls showed activation in dorsomedial PFC (dmPFC) and anterior cingulate cortex (ACC), insula, pre-and post-central gyri and parieto-occipital and cerebellar regions. ADHD patients on placebo showed activation in ACC, preand post-central gyrus, posterior cingulate (PCC), and occipito-cerebellar regions, while under fluoxetine they showed activation in right dorsolateral and inferior PFC (DLPFC/IFC)/ insula extending into basal ganglia (BG), ACC, temporo-parietal and occipital cortices and cerebellum (see Supplementary Material and Figure S1 ).
Within-group differences between ADHD patients on placebo versus fluoxetine
Repeated-measures ANCOVA revealed a significant drug effect in a large cluster comprising right IFC, insula, precentral and superior temporal cortices extending into BG, which was enhanced under fluoxetine relative to placebo (Figure 1, Table 2A ). Post-hoc calculations in SPSS indicated an observed power of 89% (partial η 2 =0.53). Activation in IFC was significantly negatively correlated in the placebo group with AUC (r=-0.676, p<0.016). Under Fluoxetine, however, the correlation was at a trend-level positive (r=0.563, p=0.057).
Under placebo relative to fluoxetine, patients had enhanced activation during delayedimmediate choices in two clusters, one comprising bilateral cerebellar hemispheres and vermis, PCC, precuneus and occipital lobe, and the other in left pre-and postcentral gyrus, extending into middle frontal gyrus and inferior parietal lobe (IPL) (Figure 1 , Table 2B ). Furthermore, activation in the cerebellum/PCC/precuneus cluster was negatively correlated with the IFC cluster that was upregulated under fluoxetine (r=-0.859, p<0.001).
Drug administration order had no effect on within-group differences in BOLD response [right Table 2 Between-group differences
Controls versus ADHD patients on placebo
Between-group ANCOVA showed significantly increased activation in controls relative to ADHD under placebo for delayed-immediate choices in 3 right-hemispheric clusters comprising right pre-and postcentral gyri, extending into IPL and insula. Patients on placebo showed increased activation relative to controls in left anterior cerebellum/occipital lobe (Table 3A , Fig 2A) . No significant correlations were observed between extracted BOLD response from these clusters and IQ. Furthermore, ANCOVA with IQ as covariate showed that all significant clusters remained with the exception of right insula. No correlations were observed between AUC and extracted BOLD response in any clusters.
Controls vs. ADHD patients on fluoxetine
Controls relative to ADHD patients on fluoxetine showed enhanced activation in left pre-and postcentral gyri reaching into IPL. No clusters were increased in ADHD relative to controls (Table 3B , Fig 2B) . Thus, the right hemispheric clusters which were enhanced in activation in controls relative to ADHD under placebo were no longer observed, suggesting that fluoxetine normalized these activation differences. No significant correlations were observed between extracted BOLD response and IQ. ANCOVA with IQ as covariate showed that all significant clusters remained. No correlations were found between AUC and extracted BOLD response in significant clusters. Table 3 DISCUSSION Behaviourally, an acute dose of fluoxetine normalised TD abnormalities in ADHD relative to controls. At the brain level, within patients, fluoxetine relative to placebo significantly upregulated activation in a large right-hemispheric IFC-premotor-insular-striatal cluster, which correlated trendwise with better TD. Fluoxetine additionally down-regulated activation in presumably default mode network activations in PCC/precuneus and in pre and postcentral gyrus/IPL as well as cerebellum.
Insert Figure 2 + Legend and
Relative to controls, patients on placebo showed underactivation in right insula, pre/postcentral gyrus and IPL but enhanced activation in left anterior cerebellum/PCC. Fluoxetine normalized all case-control differences, due to upregulation/downregulation of these regions within patients, but lead to underactivation in left-hemispheric pre/postcentral gyrus/IPL in ADHD relative to controls, due to downregulation of this activation within patients.
Fluoxetine relative to placebo upregulated a large right-lateralized cluster in ADHD comprising IFC, premotor cortex, insula and BG, which was associated trend-wise with better TD.
This right IFC-insular-striatal network comprises key regions for TD important for integrating external information with internal value representations to support goal-directed EF (Christakou et al., 2009 , Christakou et al., 2013a , Rubia et al., 2009 , Wesley and Bickel, 2014 , Wittmann et al., 2007 . Right IFC is a key cognitive control hub region, crucial for inhibiting immediate reward choices as well as for inter-temporal bridging and future reward representation (Radua et al., 2014 , Wiener et al., 2010 . The BG are linked to a reward-valuation network that mediates reinforcement learning, reward-processing and inter-temporal bridging (Koch et al., 2009, Peters and Büchel, 2011, timing functions including temporal foresight (Carter et al., 2010 , Radua et al., 2014 , Wesley and Bickel, 2014 , Wiener et al., 2010 . In particular right hemispheric IFC, insula and BG have been shown to be consistently hypoactivated in ADHD in meta-analyses of EF tasks (Cortese et al., 2012 , Hart et al., 2013 ), including TD (Chantiluke et al., 2014d , Rubia et al., 2009 . Right IFC underactivation has furthermore been shown to be disorder-specific relative to other childhood disorders such as conduct and obsessive-compulsive disorder (Norman et al., 2015 , Rubia, 2011 , Rubia et al., 2014a .
In this study, we only observed underactivation in ADHD relative to healthy adolescents in insula and premotor regions, rather than in IFC and basal ganglia, presumably due to low power.
Given that our recent meta-analysis findings of a consistent upregulation with stimulants of right IFC, insula and BG activation in ADHD (Rubia et al., 2014b) , the findings suggest that serotonin agonists may have comparable upregulatory effects to stimulants. In fact, the upregulated region in VLPFC reaching into anterior insula, putamen and superior temporal lobe is in a very similar location to the cluster observed in our meta-analysis of methylphenidate effects on ADHD brain function (Talairach coordinates: 42, 20, , with a sizeable effect size of 1 relative to the meta-analytic effect size of 1.5 (Rubia et al., 2014b) . Furthermore, it is strikingly similar to the upregulated IFC location in our fMRI studies of methylphenidate effects on inhibition and timing, with effect sizes of .7 and .2 respectively (Cubillo et al., 2014b , Rubia et al., 2014b , Smith et al., 2013 . The finding of right IFCstriatal upregulation together with normalisation of behavioural TD deficits extends previous evidence for modulation of behavioural TD rates with 5-HT (Schweighofer et al., 2008 , Schweighofer et al., 2007 and of IFC-striatal activation with 5-HT modulators such as tryptophan depletion and SSRIs in healthy adults (Del-Ben et al., 2005 , Lamar et al., 2009 , Rubia et al., 2005 to the ADHD population. It also extends our previous findings in ADHD that fluoxetine enhances and normalises frontal activation during other impulsiveness-related functions such as IFC-striatal regions during inhibition (Chantiluke et al., 2014c) and DLPFC during working memory (Chantiluke et al., 2014b) .
The findings of right IFC modulation suggest that indoleamine agonists have similar effects to catecholamine agonists on ADHD brain function, given that not only methylphenidate but also atomoxetine upregulated right IFC activation during inhibition and timing (Cubillo et al., 2014a , Cubillo et al., 2014b , Smith et al., 2013 .
The fact that fluoxetine normalised both, underactivation in right pre/postcentral gyri, insula and IPL and behavioural TD deficits in ADHD is in line with the role of lateral fronto-insular-striatoparietal circuitry in intertemporal choice (Bickel et al., 2009 , McClure et al., 2004 , Xu et al., 2009 and for the modulation of these regions by 5-HT (Cools et al., 2011 , Long et al., 2009 , Robinson et al., underactivated in ADHD during EF (Cortese et al., 2012 , Hart et al., 2012 , Hart et al., 2013 . We have found left IPL underactivation to be normalised in ADHD with fluoxetine during inhibition (Chantiluke et al., 2014c) . The upregulation and normalization with fluoxetine of insula, pre/postcentral and IPL deficits in ADHD thus provides promising novel evidence for modulatory effects of serotonin agonists on typically dysfunctional fronto-insular-parietal systems in ADHD.
The downregulation of PCC/precuneus under fluoxetine versus placebo likely reflects deactivation of the DMN, comprised of ACC, precuneus and PCC, thought to represent mindwandering, and which is typically anti-correlated with task-positive regions as it needs to be switched off during cognitive effort (Northoff et al., 2010) . This is reinforced by the negative correlation under placebo of this cluster with the IFC activation. There is accumulating evidence that the DMN is insufficiently deactivated and anticorrelated with task-positive activation in ADHD (Christakou et al., 2013b) , leading to enhanced mind-wandering, poor attention, EF and timing functions. We have found a similar effect of fluoxetine enhancing the deactivation of PCC during working memory in ADHD patients (Chantiluke et al., 2014b) , which we also observed with methylphenidate and atomoxetine (Cubillo et al., 2014a) . The finding suggests that fluoxetine, like catecholamine agonists (Rubia et al., 2014b) , can strengthen the weak deactivation of the DMN in ADHD, presumably improving mind wandering. Given that the key functional deficits in ADHD are both reduced activation in key fronto-striato-parietal networks mediating EF as well as a reduced deactivation of the DMN (Rubia et al., 2014a) , the findings suggest that a 5-HT agonist positively modulates both "task-positive" as well as "task-negative" activation deficits of not switching off the DMN.
5-HT is relatively ubiquitous in the brain. However, 5-HT modulates specifically ADHDrelevant impulsivity-related functions mediated by ventrolateral-prefrontal regions which are dependent on 5-HT input such as inhibitory control and reward-related decision making (Dalley and Roiser, 2012) . The upregulation with a 5-HT agonist of key right-hemispheric IFC-striatal activation that is typically abnormal in ADHD suggests that abnormal 5-HT may be underlying abnormal activation in these networks and not just catecholamine systems, in line with accumulating evidence of a role of 5-HT in ADHD (Barrickman et al., 1991 , Gizer et al., 2009 , Hinz et al., 2011 , McGough et al., 2009 , Oades, 2008 , Quintana et al., 2007 , Rommelse et al., 2010 , Spivak et al., 1999 , Zepf et al., 2010 . However, it cannot be ruled out that fluoxetine had no indirect effects on other neurotransmitter systems which are known to be influenced by 5-HT such as dopamine, acetylcholine and other monoamines (Bymaster et al., 2002 , Mongeau et al., 1997 , Oades, 2008 . All relevant functions (Dalley and Roiser, 2012) .
The strength of this study is a carefully selected non-comorbid ADHD group. Limitations are a relatively small patient sample size and the fact that for ethical and financial considerations, the control group was scanned only once while patients were scanned twice. However, the randomisation accounted for potential training effects, and order did not affect the results. The significantly lower IQ in the ADHD group, typical for the population, is a limitation, in particular because IQ impacts upon decision making (Toplak et al., 2010) .However, covariance and correlation findings did not suggest that IQ confounded group differences. Finally, long-term stimulant use affects brain function and structure, so deficit findings may have been mitigated by the majority of patients taking stimulant medication (Hart et al., 2012 , Rubia et al., 2014a . 
Conclusions
